News & Analysis on Clinical Trial Services & Contract Research And Development
HUYA Bioscience says it will strengthen bonds between Chinese drug innovators and worldwide developers and through its new partnership with the Tianjin Institute of Pharmaceutical Research (TIPR).
Russia’s trial sector has largely recovered from the ‘crisis’ created by revision of approval system in 2010, but regulators are still taking too long to OK studies says industry group ACTO.
Zogenix is collaborating with Battelle to out-license its needle-free drug delivery technology, DosePro.
Covance could cut early development capacity if the unit posts flat sales in the coming fiscal year, its CEO said.
Patheon will focus its upcoming growth efforts on solubility enhancing tech after receiving an influx of requests from clients.
The FDA has updated its question and answer document to help manufacturers of topical antiseptics prevent contamination.
Lpath has suspending dosing in its iSONEP clinical trials after learning the CMO handling fill and finish has cGMP failings.
update 2
BASF has hiked its prices for ethanolamines just days after asking the European Commission to review measures designed to stop US exporters selling the compound to manufacturers in Europe at less than cost.